Kategorie: Umfrage

Umfrageergebnisse: Die globale MECP2-Duplikations-Community spricht

Research on MECP2 Duplication Syndrome has taken an unprecedented step: entering the world of clinical trials. This is a spark of hope for many families who have worked tirelessly for years to provide a better future for their children. With the launch of early-stage clinical trials such as ATTUNE (ION440 by Ionis) in the U.S. […]